CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

CDMO Subsection

Insights into the latest developments in CDMO services and manufacturing.

Continue reading

Injectables Subsection

Expert perspectives on the evolving needs of injectable therapies and packaging.

Continue reading

Nasal & Pulmonary Subsection

Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability

Continue reading

Advertisement

CPHI Milan
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Lifecore Biomedical

Advertisement

Solstice
Volume 16 Issue 1

Novel Drugs: Challenging Entrenched Prescriber/Investment Behaviour is not Just About Education

Behavioural science’s time has come in the pharma industry, as medical communications adapt to a more ambitious and diverse treatment landscape. Drawing on examples ...
Continue Reading →
Volume 16 Issue 1

The End to Painfully Slow Cloud Migration?

Despite the benefits of moving to the cloud, migration can still be prohibitively time-consuming and costly, especially in a highly regulated industry like pharma. B...
Continue Reading →
Volume 15 Issue 4

Affiliates Want a Substantially Increased Role in Transforming Global RIM, Finds a Major New Global Study

New research has confirmed that in[1]country Life Sciences company affiliates feel unrepresented in the pursuit of streamlined regulatory information management on a...
Continue Reading →
Volume 15 Issue 3

Rethink, Redesign, Recycle – Pharma’s 100% PET Blister

IPI Speaks with Alberto Negra, Technical Manager at Rotor Print about creating a pharmaceutical blister that can be recycled, but without losing the properties of th...
Continue Reading →
Volume 15 Issue 3

Why Pharma Dealmaking is a Sector that’s Ripe for Growth

The global pharmaceutical sector is booming thanks to continued growth in R&D spend in new technologies and therapeutic areas, putting the industry back on a mor...
Continue Reading →
Volume 15 Issue 3

How to Make the Grade in Pharma Manufacturing

The current era in pharmaceutical manufacturing is defined by challenging market demands and stricter regulations, particularly with new, more comprehensive GMP stan...
Continue Reading →
Volume 15 Issue 2

Net Zero Healthcare – Priorities for Decarbonising the Pharma Supply Chain

The climate and our health are inextricably linked. The effects of climate change on global health systems and outcomes are already clear, with WHO proclaiming it to...
Continue Reading →
Volume 15 Issue 2

Harnessing the Power of cMaaS in Pharma Logistics

Ensuring Regulatory Compliance and Sustainable Supply Chain Management End-to-end digital visibility across the supply chain can be used to identify hotspots, sup...
Continue Reading →
Volume 15 Issue 1

Intellectual Property Matters for Economic, Social, Technological, Scientific, and Industrial Development

Q: SPL – Please tell us about ARIPO. Why was ARIPO formed and what are your core functions and visions of ARIPO? A: The African Regional Intellectual Property Org...
Continue Reading →
Volume 15 Issue 1

IPI speaks with experts at PharmaLex on Integrated Product Development

Q: Can we start with a brief history of PharmaLex, what are your key offerings into the industry? A: PharmaLex was established 25 years ago with a vision to make ...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Tjoapack
Aptar – 08/01/2026